Literature DB >> 28335082

Reporting of mitotic rate in cutaneous melanoma: A study using the national cancer data base.

Patrick D Lorimer1, Emily C Benham1, Kendall Walsh1, Yimei Han2, Meghan R Forster1, Terry Sarantou1, Richard L White1, Joshua S Hill1.   

Abstract

BACKGROUND: The seventh edition of the American Joint Commission on Cancer staging manual (AJCC7, published 2009), updated thin cutaneous melanoma staging protocols with the incorporation of mitotic rate (MR). In these patients, higher MR is associated with decreased survival. This study utilizes the National Cancer Data Base (NCDB) to evaluate MR reporting since AJCC7.
METHODS: The NCDB was queried for patients with primary cutaneous melanoma from 1998 to 2013. Because MR reporting was infrequent prior to implementing AJCC7, records from 2010 to 2013 were analyzed. Categorical variables were compared with chi-square tests; univariate and multivariate logistic regression models were constructed to determine the effects of covariates on MR reporting.
RESULTS: A total of 107,134 patients met inclusion criteria. From 2010 to 2013, MR reporting increased dramatically (64.3-80.9%). On multivariate analysis, factors significantly related to increased MR reporting include later diagnosis year, T-classification (T1a and b vs. T1), facility type (academic vs. other specified types of cancer programs), facility volume, patient income, level of education, and county population (metropolitan vs. urban and rural).
CONCLUSIONS: MR reporting increased dramatically after the introduction of AJCC7; however, disparities in reporting remain across facility types. Further investigation of procedures performed in academic settings that may influence reporting of MR is warranted. J. Surg. Oncol. 2017;115:281-286.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cutaneous melanoma; mitotic rate; pathology reporting; prognostic indicator

Mesh:

Year:  2017        PMID: 28335082     DOI: 10.1002/jso.24503

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Mitotic rate as an important prognostic factor in cutaneous malignant melanoma.

Authors:  A Piñero-Madrona; G Ruiz-Merino; P Cerezuela Fuentes; E Martínez-Barba; J N Rodríguez-López; J Cabezas-Herrera
Journal:  Clin Transl Oncol       Date:  2019-02-19       Impact factor: 3.405

Review 2.  Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies.

Authors:  Mariana B Sadurní; Alexander Meves
Journal:  Mod Pathol       Date:  2022-06-02       Impact factor: 8.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.